Zum Hauptinhalt springen

International

23. März 2021 | International

USA. What are the barriers to starting and maintaining a program of medication treatment in healthcare settings?

USA. What are the barriers to starting and maintaining a program of medication treatment in healthcare settings? Opioid use disorder (OUD) medications are effective life-saving treatments that help support recovery. However, only about one-third of…

21. März 2021 | International

Changes in opioid-related deaths following increased access to opioid substitution treatment.

Changes in opioid-related deaths following increased access to opioid substitution treatment. Andersson L, Håkansson A, Berge J, Johnson B. Subst Abuse Treat Prev Policy. 2021 Feb 10;16(1):15. doi: 10.1186/s13011-021-00351-4. PMID: 335…

21. März 2021 | International

Facilitators and Barriers to Nurse Practitioners Prescribing Methadone for Opioid Use Disorder in Nova Scotia: A Qualitative Study.

Facilitators and Barriers to Nurse Practitioners Prescribing Methadone for Opioid Use Disorder in Nova Scotia: A Qualitative Study. Bates AE, Martin-Misener R. Can J Nurs Res. 2021 Feb 20:844562121996222. doi: 10.1177/0844562121996222…

21. März 2021 | International

Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes.

Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes. Khan A, Khan Q, Kolb E. J Subst Abuse Treat. 2021 Apr;123:108256. doi: 10.1016/j.jsat.2020.108256. Epub 2020 Dec 18. PMID: 336121…

21. März 2021 | International

Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.

Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care. Dela Cruz AM, Walker R, Pipes R, Wakhlu S, Trivedi MH. Addict Sci Clin Pract. 2021 Feb 19;16(1):12. doi: 10.1186/…

14. März 2021 | International

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report.

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report. Guillou-Landreat M, Dany A, Challet-Bouju G, Laforgue E, Leboucher J, Benoit Hardouin J…

14. März 2021 | International

Linking opioid use disorder treatment from hospital to community.

Linking opioid use disorder treatment from hospital to community. Brothers, T. D., Lewer, D., and Thakrar, A. P. (2021) Addiction, doi.org/10.1111/add.15460. https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.15460

Weitere
akutelle Informationen
zu den Themengebieten